Skip to main content
Safety-Related Labeling Changes
Interactions with oral anticoagulants, Cytochrome (CYP2C19) inhibitors, hypokalaemia-/ hypomagnesaemia inducing drugs and drugs that metabolised by Cytochrome (CYP2D6) enzyme
Trade Name
Cipram
Updated Section
4.5. Interactions with other medicinal products
Month
Apr,2023